4.7 Review

Nanodelivery of cGAS-STING activators for tumor immunotherapy

Related references

Note: Only part of the references are listed.
Article Engineering, Biomedical

Biomimetic manganese-based theranostic nanoplatform for cancer multimodal imaging and twofold immunotherapy

Yuyue Zhao et al.

Summary: We have developed a nanoplatform capable of improving the immunosuppressive tumor microenvironment (TME) by actively targeting it. By camouflaging the surface of gold nanorods (GNRs) with myeloid-derived suppressor cells (MDSCs) membrane, we have achieved targeted adjustment of the TME. This nanoplatform also enables multimodal cancer imaging and dual immunotherapy.

BIOACTIVE MATERIALS (2023)

Article Chemistry, Multidisciplinary

Dual agonist immunostimulatory nanoparticles combine with PD1 blockade for curative neoadjuvant immunotherapy of aggressive cancers

Prabhani U. Atukorale et al.

Summary: This study evaluated the efficacy of neoadjuvant combination immunotherapy in treating aggressive cancer by combining the anti-PD1 checkpoint inhibitor with immunostimulatory nanoparticles. The results showed that the combination treatment activated the immune system, significantly improving tumor clearance and inducing protective immune memory.

NANOSCALE (2022)

Article Biotechnology & Applied Microbiology

Extracellular matrix-degrading STING nanoagonists for mild NIR-II photothermal-augmented chemodynamic-immunotherapy

Meixiao Zhan et al.

Summary: This study presents a nanoagonist that can activate the STING pathway through NIR-II light irradiation and promote immunotherapy for breast cancer. The nanoagonist effectively inhibits primary and distant tumors as well as reduces liver and lung metastasis.

JOURNAL OF NANOBIOTECHNOLOGY (2022)

Article Pharmacology & Pharmacy

Tetrahedral DNA nanostructures synergize with MnO2 to enhance antitumor immunity via promoting STING activation and M1 polarization

Siping Liang et al.

Summary: The study found that tetrahedral DNA nanostructures (TDNs) can enter macrophages and enhance STING activation and M1 polarization in synergy with Mn2 +, leading to an enhanced anti-tumor response. By constructing a TDN-MnO2 complex, the cytotoxicity of Mn2 + can be reduced while promoting macrophage activation and anti-tumor response.

ACTA PHARMACEUTICA SINICA B (2022)

Article Chemistry, Multidisciplinary

Self-degradable poly(β-amino ester)s promote endosomal escape of antigen and agonist

Hong Liu et al.

Summary: Vaccination with subunit nanovaccines loaded with STING agonists and subunit antigens shows promising results in combating virus infection and tumor development. The nanovaccine exhibited strong immunogenicity, remodeled the tumor microenvironment, and inhibited tumor progression, increasing the survival rates of animals.

JOURNAL OF CONTROLLED RELEASE (2022)

Article Chemistry, Multidisciplinary

Systemic nano-delivery of low-dose STING agonist targeted to CD103+dendritic cells for cancer immunotherapy

Aatman S. Doshi et al.

Summary: In this study, a systemically administered CD103+ dendritic cell (DCs) targeted liposomal formulation was developed, which enhanced anti-tumor immune response and reduced off-target toxicities by targeted delivery of CDNs. The results showed significant anti-tumor efficacy of the liposomal formulation at low dose.

JOURNAL OF CONTROLLED RELEASE (2022)

Article Multidisciplinary Sciences

Activation of STING by targeting a pocket in the transmembrane domain

Defen Lu et al.

Summary: STING is an adaptor protein in innate immunity against DNA viruses or bacteria. Activation of STING through a small-molecule agonist, C53, can promote immune response. C53 binds to a cryptic pocket in the STING transmembrane domain, inducing oligomerization and activation of STING.

NATURE (2022)

Article Chemistry, Physical

STING agonist delivery by tumour-penetrating PEG-lipid nanodiscs primes robust anticancer immunity

Eric L. Dane et al.

Summary: Lipid nanodiscs functionalized with STING-activating cyclic dinucleotides demonstrate superior tumour penetration and tumour cell uptake, leading to enhanced antitumour T-cell priming and tumour regression.

NATURE MATERIALS (2022)

Article Engineering, Biomedical

Polymersome-mediated cytosolic delivery of cyclic dinucleotide STING agonist enhances tumor immunotherapy

Huan Zheng et al.

Summary: Research has found that reduction-responsive biodegradable chimaeric polymersomes (CPs) can enhance tumor retention and cytosolic delivery of synthetic CDN, leading to improved activation of the STING pathway in the tumor microenvironment and better tumor repression and survival.

BIOACTIVE MATERIALS (2022)

Article Engineering, Biomedical

Targeted delivery of a STING agonist to brain tumors using bioengineered protein nanoparticles for enhanced immunotherapy

Bin Wang et al.

Summary: Immunotherapy is a powerful tool for combating human diseases, but its application in serious brain diseases is limited due to a lack of effective drug delivery technologies. In this study, researchers developed bioengineered ferritin nanoparticles that could transport a small-molecule immunomodulator across the blood-brain barrier and target specific cells in a glioma mouse model. These nanoparticles showed enhanced immunotherapeutic efficacy and resulted in tumor growth inhibition and prolonged survival. This biomimetic brain delivery platform offers new opportunities for brain drug delivery and immunotherapy in glioma patients.

BIOACTIVE MATERIALS (2022)

Review Pharmacology & Pharmacy

Immunological perspectives on spatial and temporal vaccine delivery

Mingzhao Zhu

Summary: Rational vaccine design is considered an important direction in research and development, with lymph node targeting being a popular strategy for enhancing vaccine efficacy. In addition to LN targeting, cellular targeting and even subcellular compartment targeting should be considered to optimize immune response.

ADVANCED DRUG DELIVERY REVIEWS (2021)

Article Chemistry, Multidisciplinary

Nanoparticle-Mediated Delivery of Inhaled Immunotherapeutics for Treating Lung Metastasis

Qiutong Jin et al.

Summary: This study developed an inhaled immunotherapeutic chitosan-antibody complex that effectively activates the immune system, promotes infiltration of different immune cells around tumor lesions, and prolongs the survival of mice.

ADVANCED MATERIALS (2021)

Article Engineering, Biomedical

In situ activation of STING pathway with polymeric SN38 for cancer chemoimmunotherapy

Jiayu Zhao et al.

Summary: The study presented a method for in situ activation of the STING pathway using nanoparticles to deliver DNA-targeting chemo agents, demonstrating the potent ability of SN38 in stimulating interferon secretion and activating the STING pathway. The nanoparticle formulation effectively stimulated STING pathway activation, resulting in significant tumor suppression.

BIOMATERIALS (2021)

Article Biochemistry & Molecular Biology

Synthesis and biological evaluation of all possible inosine-mixed cyclic dinucleotides that activate different hSTING variants

Zhenghua Wang et al.

Summary: Inosine-containing CDNs have the potential to activate all five major hSTING variants, showing promise as novel immune therapy activators. Molecular dynamic simulations and ITC assays further confirm the interaction mechanisms, providing insights for future drug development.

BIOORGANIC & MEDICINAL CHEMISTRY (2021)

Review Pharmacology & Pharmacy

Recent advances in HER2-targeted delivery for cancer therapy

Rakesh Kumar Dhritlahre et al.

Summary: HER2 is overexpressed in several cancers and plays a crucial role in cancer cell activities, making it an ideal target for therapy. Various strategies and delivery systems can be utilized to enhance cancer treatment outcomes.

DRUG DISCOVERY TODAY (2021)

Article Chemistry, Medicinal

The discovery of potent small molecule activators of human STING

David C. Pryde et al.

Summary: A study identified several potent small molecule human STING activators, which have the potential to be developed as immunomodulatory therapeutics. These compounds demonstrated significant on-target activation of STING in cells, showing promise for the development of therapeutic drugs.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Review Pharmacology & Pharmacy

EGFR and anti-EGFR nanobodies: review and update

Jafar Sharifi et al.

Summary: This review discusses the use of nanobodies in targeted therapy, focusing on recent advancements and future prospects in targeting EGFR.

JOURNAL OF DRUG TARGETING (2021)

Article Chemistry, Multidisciplinary

Considerations for the delivery of STING ligands in cancer immunotherapy

M. Petrovic et al.

Summary: Studies have shown the significance of the cGAS-STING pathway in anticancer immunity, but issues exist with cGAMP as a ligand, such as susceptibility to degradation and difficulty in transfecting into negatively charged membrane cells. Therefore, a suitable carrier is needed to enhance transfection efficiency and protect cGAMP.

JOURNAL OF CONTROLLED RELEASE (2021)

Review Pharmacology & Pharmacy

Tumor microenvironment remodeling-based penetration strategies to amplify nanodrug accessibility to tumor parenchyma q

Yanhong Liu et al.

Summary: Significant advances in nano delivery systems offer new hope for tumor prevention, diagnosis, and treatment, but challenges persist in achieving clinical therapeutic effects against solid tumors. Biological barriers, such as abnormal tumor vasculature and abundant stroma cells within the tumor microenvironment (TME), impede the penetration and distribution of nanodrugs. Advanced strategies for TME remodeling are reviewed to overcome these obstacles and facilitate intratumoral permeation of nanodrugs.

ADVANCED DRUG DELIVERY REVIEWS (2021)

Review Chemistry, Medicinal

STING, a promising target for small molecular immune modulator: A review

Yijun Liu et al.

Summary: STING is a crucial player in the human innate immune system, activating production of interferons and cytokines to combat infections, inflammation, and tumorigenesis. Research focuses on STING's structure, function, regulation, and small molecule modulators for potential therapeutic applications.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Nanoscience & Nanotechnology

Amplifying STING activation by cyclic dinucleotide-manganese particles for local and systemic cancer metalloimmunotherapy

Xiaoqi Sun et al.

Summary: Metalloimmunotherapy utilizes metal ions to amplify the anti-tumour immune response promoted by STING agonists, forming nanoparticles that effectively deliver STING agonists and achieve remarkable therapeutic efficacy in multiple tumour models. This work highlights the great potential of coordination nanomedicine for metalloimmunotherapy.

NATURE NANOTECHNOLOGY (2021)

Review Nanoscience & Nanotechnology

Carbon Nanotubes: Smart Drug/GeneDelivery Carriers

Hossein Zare et al.

Summary: Carbon nanotubes have unique properties that make them suitable for drug and gene delivery, as well as applications in cancer therapy, anti-inflammatory treatments, and phototherapy. However, concerns about nanotoxicity and environmental impact remain, despite decades of research and potential benefits.

INTERNATIONAL JOURNAL OF NANOMEDICINE (2021)

Review Pharmacology & Pharmacy

Biological Cells as Therapeutic Delivery Vehicles

Lucas M. Bush et al.

Summary: Live cells have innate targeting mechanisms and can be used as drug-delivery vehicles to increase drug accumulation efficiency. In cases where native cell types do not exhibit the desired therapeutic phenotype, preferred outcomes can be achieved by genetically modifying and reprogramming cells. Recent advances in using cells like red blood cells, platelets, neutrophils, mesenchymal stem cells, and bacteria for drug delivery have been highlighted in this review.

TRENDS IN PHARMACOLOGICAL SCIENCES (2021)

Article Oncology

Influence of injection technique, drug formulation and tumor microenvironment on intratumoral immunotherapy delivery and efficacy

Nina M. Munoz et al.

Summary: Injection technique, drug formulation, and tumor stiffness are crucial factors in the accurate delivery of intratumoral immunotherapeutics. Modifying these variables can significantly impact the distribution of drugs within tumors and treatment efficacy.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

Article Engineering, Biomedical

Prolonged activation of innate immune pathways by a polyvalent STING agonist

Suxin Li et al.

Summary: A novel polyvalent STING agonist extends the activation of innate-immunity pathways through the formation of STING condensates and leads to synergistic therapeutic outcomes in vivo when combined with the STING ligand cGAMP.

NATURE BIOMEDICAL ENGINEERING (2021)

Review Biochemistry & Molecular Biology

The cGAS-STING pathway: more than fighting against viruses and cancer

Terigen Bao et al.

Summary: The cGAS-STING pathway plays a crucial role in chronic inflammatory diseases, particularly in relation to lipid metabolism. Current research suggests that targeted therapy for diseases possibly caused by the cGAS-STING pathway shows promising outcomes.

CELL AND BIOSCIENCE (2021)

Article Chemistry, Medicinal

Identification of Novel Carbocyclic Pyrimidine Cyclic Dinucleotide STING Agonists for Antitumor Immunotherapy Using Systemic Intravenous Route

Stepan Vyskocil et al.

Summary: STING activation leads to both acute innate immune response and adaptive immune response, providing robust antitumor efficacy.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Nanoscience & Nanotechnology

Co-delivery of Phagocytosis Checkpoint Silencer and Stimulator of Interferon Genes Agonist for Synergetic Cancer Immunotherapy

Zi-Dong Lu et al.

Summary: This study developed a co-delivery immunotherapeutic strategy targeting the phagocytosis checkpoint SIRP alpha and STING of APCs to enhance tumor antigen capture and presentation, activation of CD8(+) T cells, and induction of holistic anti-tumor immune responses. The strategy synergistically enhanced APC functions and can potentially be applied to tumors with poor immunogenicity.

ACS APPLIED MATERIALS & INTERFACES (2021)

Review Chemistry, Multidisciplinary

Lipid Nanoparticles-From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement

Rumiana Tenchov et al.

Summary: Lipid nanoparticles (LNPs) have become promising vehicles in the pharmaceutical industry for delivering various therapeutics, particularly highlighted in the COVID-19 mRNA vaccines. LNPs exhibit versatility and physical stability, allowing for targeted delivery of therapeutic drugs to specific locations within the body. Liposomes, an early version of LNPs, have already been widely applied in medical practice.

ACS NANO (2021)

Review Pharmacology & Pharmacy

Liposome composition in drug delivery design, synthesis, characterization, and clinical application

Danielle E. Large et al.

Summary: Liposomal drug delivery is a highly adaptable therapeutic platform for treating a wide range of diseases. The molecular diversity in liposome composition enables drug delivery with unique physiological functions, such as pH response and reduced systemic toxicity.

ADVANCED DRUG DELIVERY REVIEWS (2021)

Review Chemistry, Multidisciplinary

Solid lipid nanoparticles for hydrophilic drugs

Yashika Mirchandani et al.

Summary: Hydrophilic drugs are effective therapeutic agents, but the delivery of these drugs presents challenges. Various colloidal drug delivery systems have been developed to enhance drug entrapment and bioavailability, but issues like drug leakage and burst release remain. Solid lipid nanoparticles (SLNs) have been proposed as an alternative to overcome these issues, and research is focusing on different approaches for the delivery of hydrophilic drugs using SLNs.

JOURNAL OF CONTROLLED RELEASE (2021)

Article Oncology

STING agonist loaded lipid nanoparticles overcome anti-PD-1 resistance in melanoma lung metastasis via NK cell activation

Takashi Nakamura et al.

Summary: STING-LNP treatment can overcome PD-1 resistance by activating NK cells, resulting in an increase in PD-L1 expression on cancer cells and ultimately producing a synergistic antitumor effect.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

Review Oncology

The dark side of immunotherapy

Nwanneka Okwundu et al.

Summary: Immunotherapy has expanded treatment options for cancer patients, with drugs like immune checkpoint inhibitors showing effectiveness against various tumor types. However, these treatments may come with significant adverse events that need to be carefully monitored.

ANNALS OF TRANSLATIONAL MEDICINE (2021)

Review Chemistry, Multidisciplinary

Inorganic nanomaterials with rapid clearance for biomedical applications

Xianwen Wang et al.

Summary: Inorganic nanomaterials have great potential in biomedicine, but long-term accumulation in healthy tissues can cause toxicity. The emergence of biodegradable and clearable inorganic nanomaterials provides a way to prevent such toxicity, and a comprehensive understanding of their design and metabolic pathways is essential for expanding therapeutic applications for various diseases.

CHEMICAL SOCIETY REVIEWS (2021)

Review Materials Science, Biomaterials

Polysaccharide nanoparticles: from fabrication to applications

Alexander Plucinski et al.

Summary: Polysaccharides have gained significant attention in various applications due to their unique properties, leading to research efforts in developing polysaccharide nanoparticles for diverse applications. The combination of polysaccharide nanoparticles and polymers has been explored, along with their applications in nanomedicine, cosmetics, and food systems. Challenges and directions for further utilization of polysaccharide nanoparticles in the future are also discussed.

JOURNAL OF MATERIALS CHEMISTRY B (2021)

Review Engineering, Biomedical

Targeting strategies for superparamagnetic iron oxide nanoparticles in cancer therapy

Defu Zhi et al.

ACTA BIOMATERIALIA (2020)

Review Pharmacology & Pharmacy

Bioactive modulators targeting STING adaptor in cGAS-STING pathway

Xi Feng et al.

DRUG DISCOVERY TODAY (2020)

Review Engineering, Biomedical

Cell membrane-camouflaged nanoparticles as drug carriers for cancer therapy

Cheng-Hui Xu et al.

ACTA BIOMATERIALIA (2020)

Article Chemistry, Medicinal

Targeting Stimulator of Interferon Genes (STING): A Medicinal Chemistry Perspective

Han Zhang et al.

JOURNAL OF MEDICINAL CHEMISTRY (2020)

Review Pharmacology & Pharmacy

Membrane-core nanoparticles for cancer nanomedicine

Jianfeng Guo et al.

ADVANCED DRUG DELIVERY REVIEWS (2020)

Article Engineering, Biomedical

Multifunctional STING-Activating Mn3O4@Au-dsDNA/DOX Nanoparticle for Antitumor Immunotherapy

Min Zhou et al.

ADVANCED HEALTHCARE MATERIALS (2020)

Article Chemistry, Multidisciplinary

Engineering Polymeric Prodrug Nanoplatform for Vaccination Immunotherapy of Cancer

Lei Zhou et al.

NANO LETTERS (2020)

Review Pharmacology & Pharmacy

Small molecules targeting the innate immune cGAS-STING-TBK1 signaling pathway

Chunyong Ding et al.

ACTA PHARMACEUTICA SINICA B (2020)

Review Cell Biology

Molecular mechanisms and cellular functions of cGAS-STING signalling

Karl-Peter Hopfner et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)

Review Pharmacology & Pharmacy

Lipid nanoparticles for nucleic acid delivery: Current perspectives

Eleni Samaridou et al.

ADVANCED DRUG DELIVERY REVIEWS (2020)

Article Biochemistry & Molecular Biology

Discovery of triazoloquinoxaline as novel STING agonists via structure-based virtual screening

Hui Hou et al.

BIOORGANIC CHEMISTRY (2020)

Review Biochemistry & Molecular Biology

cGAS-STING pathway in cancer biotherapy

Yang Wang et al.

MOLECULAR CANCER (2020)

Article Multidisciplinary Sciences

Nanoparticle-enhanced chemo-immunotherapy to trigger robust antitumor immunity

Jingjing Liang et al.

SCIENCE ADVANCES (2020)

Review Nanoscience & Nanotechnology

A Review on the Synthesis and Functionalization of Gold Nanoparticles as a Drug Delivery Vehicle

Sundus Jabeen Amina et al.

INTERNATIONAL JOURNAL OF NANOMEDICINE (2020)

Article Multidisciplinary Sciences

Polycarbonate-based ultra-pH sensitive nanoparticles improve therapeutic window

Xu Wang et al.

NATURE COMMUNICATIONS (2020)

Article Multidisciplinary Sciences

An orally available non-nucleotide STING agonist with antitumor activity

Bo-Sheng Pan et al.

SCIENCE (2020)

Article Multidisciplinary Sciences

Antitumor activity of a systemic STING-activating non-nucleotide cGAMP mimetic

Emily N. Chin et al.

SCIENCE (2020)

Review Multidisciplinary Sciences

cGAS in action: Expanding roles in immunity and inflammation

Andrea Ablasser et al.

SCIENCE (2019)

Review Biochemistry & Molecular Biology

Pharmacological Modulation of the STING Pathway for Cancer Immunotherapy

Gilles Berger et al.

TRENDS IN MOLECULAR MEDICINE (2019)

Article Chemistry, Multidisciplinary

Poly(β-amino ester)-based gene delivery systems: From discovery to therapeutic applications

Rosemeyre A. Cordeiro et al.

JOURNAL OF CONTROLLED RELEASE (2019)

Article Medicine, Research & Experimental

cGAS/STING axis mediates a topoisomerase II inhibitor induced tumor immunogenicity

Zining Wang et al.

JOURNAL OF CLINICAL INVESTIGATION (2019)

Article Biochemistry & Molecular Biology

Cisplatin-induced immune modulation in ovarian cancer mouse models with distinct inflammation profiles

Shannon Grabosch et al.

ONCOGENE (2019)

Review Medicine, Research & Experimental

Alliance with EPR Effect: Combined Strategies to Improve the EPR Effect in the Tumor Microenvironment

Jooho Park et al.

THERANOSTICS (2019)

Review Chemistry, Multidisciplinary

Block Copolymer Micelles in Nanomedicine Applications

Horacio Cabral et al.

CHEMICAL REVIEWS (2018)

Review Pharmacology & Pharmacy

Advances and applications of block-copolymer-based nanoformulations

Vibhuti Agrahari et al.

DRUG DISCOVERY TODAY (2018)

Review Chemistry, Multidisciplinary

Saccharides, oligosaccharides, and polysaccharides nanoparticles for biomedical applications

Farzad Seidi et al.

JOURNAL OF CONTROLLED RELEASE (2018)

Review Pharmacology & Pharmacy

Mesoporous silica nanoparticles for drug and gene delivery

Yixian Zhou et al.

ACTA PHARMACEUTICA SINICA B (2018)

Review Nanoscience & Nanotechnology

Gold nanoparticles enlighten the future of cancer theranostics

Jianfeng Guo et al.

INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)

Review Chemistry, Medicinal

Targeted Drug Delivery via Folate Receptors for the Treatment of Brain Cancer: Can the Promise Deliver?

Jianfeng Guo et al.

JOURNAL OF PHARMACEUTICAL SCIENCES (2017)

Review Chemistry, Multidisciplinary

Synthetic polypeptides: from polymer design to supramolecular assembly and biomedical application

Ziyuan Song et al.

CHEMICAL SOCIETY REVIEWS (2017)

Article Pharmacology & Pharmacy

A cell-based high throughput screening assay for the discovery of cGAS-STING pathway agonists

Bowei Liu et al.

ANTIVIRAL RESEARCH (2017)

Review Pharmacology & Pharmacy

Physical and mechanical properties of PLA, and their functions in widespread applications - A comprehensive review

Shady Farah et al.

ADVANCED DRUG DELIVERY REVIEWS (2016)

Review Pharmacology & Pharmacy

PEGylation as a strategy for improving nanoparticle-based drug and gene delivery

Jung Soo Suk et al.

ADVANCED DRUG DELIVERY REVIEWS (2016)

Article Pharmacology & Pharmacy

Discovery of PSMA-specific peptide ligands for targeted drug delivery

Wei Jin et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2016)

Article Multidisciplinary Sciences

Modulation of the cGAS-STING DNA sensing pathway by gammaherpesviruses

Zhe Ma et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)

Article Materials Science, Biomaterials

Nanoparticle-protein corona complexes govern the biological fates and functions of nanoparticles

Cindy Gunawan et al.

JOURNAL OF MATERIALS CHEMISTRY B (2014)

Review Biochemistry & Molecular Biology

DNA-Damaging Agents in Cancer Chemotherapy: Serendipity and Chemical Biology

Kahlin Cheung-Ong et al.

CHEMISTRY & BIOLOGY (2013)

Review Biochemistry & Molecular Biology

The transferrin receptor and the targeted delivery of therapeutic agents against cancer

Tracy R. Daniels et al.

BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2012)

Review Pharmacology & Pharmacy

CD44: a validated target for improved delivery of cancer therapeutics

Sukhen C. Ghosh et al.

EXPERT OPINION ON THERAPEUTIC TARGETS (2012)

Review Chemistry, Multidisciplinary

E-selectin as a target for drug delivery and molecular imaging

Emile Jubeli et al.

JOURNAL OF CONTROLLED RELEASE (2012)

Review Chemistry, Multidisciplinary

PLGA-based nanoparticles: An overview of biomedical applications

Fabienne Danhier et al.

JOURNAL OF CONTROLLED RELEASE (2012)

Review Pharmacology & Pharmacy

Lymphatic drug delivery using engineered liposomes and solid lipid nanoparticles

Shuang Cai et al.

ADVANCED DRUG DELIVERY REVIEWS (2011)

Review Pharmacology & Pharmacy

Part I: Targeted Particles for Cancer Immunotherapy

Samar Hamdy et al.

CURRENT DRUG DELIVERY (2011)

Article Multidisciplinary Sciences

STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling

Hiroki Ishikawa et al.

NATURE (2008)

Article Biochemistry & Molecular Biology

3′,5′-Cyclic diguanylic acid (c-di-GMP) inhibits basal and growth factor-stimulated human colon cancer cell proliferation

DKR Karaolis et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)